Daniel Blessborn

1.3k total citations · 1 hit paper
28 papers, 882 citations indexed

About

Daniel Blessborn is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Pharmacology. According to data from OpenAlex, Daniel Blessborn has authored 28 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Public Health, Environmental and Occupational Health, 12 papers in Pharmacology and 8 papers in Pharmacology. Recurrent topics in Daniel Blessborn's work include Malaria Research and Control (18 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Mosquito-borne diseases and control (7 papers). Daniel Blessborn is often cited by papers focused on Malaria Research and Control (18 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Mosquito-borne diseases and control (7 papers). Daniel Blessborn collaborates with scholars based in Thailand, United Kingdom and Sweden. Daniel Blessborn's co-authors include Yngve Bergqvist, Joel Tärning, Niklas Lindegårdh, Nicholas J. White, Lijiang Song, Chanaki Amaratunga, Pharath Lim, Roberto Amato, Seila Suon and Gregory Tullo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Daniel Blessborn

26 papers receiving 863 citations

Hit Papers

Dihydroartemisinin–piperaquine resistance in Plasmodium f... 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Blessborn Thailand 17 646 234 185 107 100 28 882
Anna Annerberg Thailand 19 805 1.2× 306 1.3× 344 1.9× 129 1.2× 134 1.3× 21 1.1k
Brioni R. Moore Australia 17 540 0.8× 144 0.6× 95 0.5× 55 0.5× 72 0.7× 56 726
Mark Baker Switzerland 14 403 0.6× 155 0.7× 141 0.8× 60 0.6× 131 1.3× 22 757
Lars Rombo Sweden 23 1.0k 1.6× 121 0.5× 263 1.4× 125 1.2× 86 0.9× 75 1.4k
Victor Meléndez United States 21 588 0.9× 170 0.7× 250 1.4× 97 0.9× 229 2.3× 39 1.2k
K Na‐Bangchang Thailand 19 645 1.0× 230 1.0× 263 1.4× 54 0.5× 57 0.6× 45 866
J Karbwang Thailand 16 589 0.9× 193 0.8× 375 2.0× 66 0.6× 111 1.1× 29 859
Michael D. Edstein Australia 25 891 1.4× 257 1.1× 230 1.2× 86 0.8× 105 1.1× 70 1.4k
Warunee Hanpithakpong Thailand 22 702 1.1× 228 1.0× 301 1.6× 130 1.2× 179 1.8× 38 1.4k
S. Pukrittayakamee Thailand 22 888 1.4× 121 0.5× 235 1.3× 47 0.4× 109 1.1× 37 1.2k

Countries citing papers authored by Daniel Blessborn

Since Specialization
Citations

This map shows the geographic impact of Daniel Blessborn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Blessborn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Blessborn more than expected).

Fields of papers citing papers by Daniel Blessborn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Blessborn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Blessborn. The network helps show where Daniel Blessborn may publish in the future.

Co-authorship network of co-authors of Daniel Blessborn

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Blessborn. A scholar is included among the top collaborators of Daniel Blessborn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Blessborn. Daniel Blessborn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blessborn, Daniel, et al.. (2023). A high-throughput LC-MS/MS assay for piperaquine from dried blood spots: Improving malaria treatment in resource-limited settings. SHILAP Revista de lepidopterología. 31. 19–26.
2.
Chu, Cindy S., James A Watson, Aung Pyae Phyo, et al.. (2021). Determinants of Primaquine and Carboxyprimaquine Exposures in Children and Adults with Plasmodium vivax Malaria. Antimicrobial Agents and Chemotherapy. 65(11). e0130221–e0130221. 6 indexed citations
3.
Tärning, Joel, et al.. (2021). High-throughput quantitation method for amodiaquine and desethylamodiaquine in plasma using supported liquid extraction technology. Journal of Chromatography B. 1179. 122887–122887. 4 indexed citations
4.
Ding, Junjie, Matthew E. Coldiron, Ousmane Guindo, et al.. (2019). Adherence and Population Pharmacokinetic Properties of Amodiaquine When Used for Seasonal Malaria Chemoprevention in African Children. Clinical Pharmacology & Therapeutics. 107(5). 1179–1188. 19 indexed citations
5.
Byakika‐Kibwika, Pauline, Ronald Ssenyonga, Mohammed Lamorde, Daniel Blessborn, & Joel Tärning. (2019). Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine. BMC Infectious Diseases. 19(1). 1025–1025. 7 indexed citations
6.
Jittamala, Podjanee, Borimas Hanboonkunupakarn, Sasithon Pukrittayakamee, et al.. (2018). Enantiospecific pharmacokinetics and drug–drug interactions of primaquine and blood-stage antimalarial drugs. Journal of Antimicrobial Chemotherapy. 73(11). 3102–3113. 19 indexed citations
7.
Chotsiri, Palang, Thanaporn Wattanakul, Richard M. Hoglund, et al.. (2017). Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin–piperaquine in healthy volunteers. British Journal of Clinical Pharmacology. 83(12). 2752–2766. 24 indexed citations
8.
Blessborn, Daniel, et al.. (2017). Quantification of the antimalarial drug pyronaridine in whole blood using LC–MS/MS — Increased sensitivity resulting from reduced non-specific binding. Journal of Pharmaceutical and Biomedical Analysis. 146. 214–219. 8 indexed citations
9.
Amaratunga, Chanaki, Pharath Lim, Seila Suon, et al.. (2016). Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. The Lancet Infectious Diseases. 16(3). 357–365. 329 indexed citations breakdown →
10.
Tchaparian, Eskouhie, Nancy C. Sambol, Emmanuel Arinaitwe, et al.. (2016). Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria. The Journal of Infectious Diseases. 214(8). 1243–1251. 15 indexed citations
11.
Ursing, Johan, Staffan Eksborg, Lars Rombo, et al.. (2014). Chloroquine Is Grossly Under Dosed in Young Children with Malaria: Implications for Drug Resistance. PLoS ONE. 9(1). e86801–e86801. 16 indexed citations
12.
Ngasala, Billy, Maja Malmberg, Anja M. Carlsson, et al.. (2011). Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study. Malaria Journal. 10(1). 64–64. 36 indexed citations
13.
Malmberg, Maja, Anja M. Carlsson, Pedro Eduardo Ferreira, et al.. (2011). Efficacy and Effectiveness of Artemether-Lumefantrine after Initial and Repeated Treatment in Children < 5 Years of Age with Acute Uncomplicated Plasmodium falciparum Malaria in Rural Tanzania: A Randomized Trial. Clinical Infectious Diseases. 52(7). 873–882. 51 indexed citations
14.
Ursing, Johan, Poul‐Erik Kofoed, Amabélia Rodrigues, et al.. (2010). Similar Efficacy and Tolerability of Double-Dose Chloroquine and Artemether-Lumefantrine for Treatment of Plasmodium falciparum Infection in Guinea-Bissau: A Randomized Trial. The Journal of Infectious Diseases. 203(1). 109–116. 36 indexed citations
15.
Blessborn, Daniel, et al.. (2007). Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper. Journal of Pharmaceutical and Biomedical Analysis. 45(2). 282–287. 56 indexed citations
16.
Lindegårdh, Niklas, Daniel Blessborn, & Yngve Bergqvist. (2005). Simultaneous Quantitation of the Highly Lipophilic Atovaquone and Hydrophilic Strong Basic Proguanil and Its Metabolites Using a New Mixed-Mode SPE Approach and Steep-Gradient LC. Journal of Chromatographic Science. 43(5). 259–266. 9 indexed citations
17.
Blessborn, Daniel, et al.. (2005). A new approach to evaluate stability of amodiaquine and its metabolite in blood and plasma. Journal of Pharmaceutical and Biomedical Analysis. 41(1). 207–212. 17 indexed citations
18.
Lindegårdh, Niklas, Anna Annerberg, Daniel Blessborn, et al.. (2004). Development and validation of a bioanalytical method using automated solid-phase extraction and LC-UV for the simultaneous determination of lumefantrine and its desbutyl metabolite in plasma. Journal of Pharmaceutical and Biomedical Analysis. 37(5). 1081–1088. 48 indexed citations
19.
Annerberg, Anna, Niklas Lindegårdh, Daniel Blessborn, Yngve Bergqvist, & Nicole White. (2004). A bioanalytical method using automated solid-phase extraction and LC-UV for the simultaneous determination of lumefantrine and its desbutyl metabolite in plasma. 1 indexed citations
20.
Blessborn, Daniel, Niklas Lindegårdh, Örjan Ericsson, Urban Hellgren, & Yngve Bergqvist. (2003). Determination of Pyronaridine in Whole Blood by Automated Solid Phase Extraction and High-Performance Liquid Chromatography. Therapeutic Drug Monitoring. 25(3). 264–270. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026